Search the site

Community and Food Environments study

Gina Nicole Trapp Hanna BHSc(Hons1A), RPHNutr, PhD BHlthSc (Hons) Honorary Research Associate Program Manager 08 6319 1033 Gina.Trapp@thekids.org.au

Wellbeing and Type 1 Diabetes

A community-led, trauma-informed psychosocial intervention to improve health outcomes of children and young people with Type-1 diabetes.

Co-designing a trauma-informed program for parents whose infant has had a Neonatal Intensive Care Unit (NICU) admission

Having a newborn child admitted into a NICU can be highly traumatic for parents. The compounding effects of the NICU clinical environment, having a seriously ill child, in addition to the inability to care or adequately bond with your child can be extremely distressing.

COMBAT CF: A phase 3 multi-centre randomized placebo-controlled study of azithromycin in the primary prevention of radiologically-defined bronchiectasis in infants with cystic fibrosis.

A phase 3 multi-centre randomized placebo-controlled study of azithromycin in the primary prevention of radiologically-defined bronchiectasis in infants with cystic fibrosis

SHIP CT: A Phase 3 randomised, double-blind, controlled trial of inhaled 7% hypertonic saline versus 0.9% isotonic saline for 48 weeks in patients with Cystic Fibrosis at 3-6 years of age in parallel with the North American SHIP clinical trial.

SHIP-CT, led by Professor Stephen Stick, Director of the Wal-yan Respiratory Research Centre at The Kids, is a unique study in preschool-aged children (from 3-6 years of age) with CF using images of the lung from chest CT scans as the main outcome measure.

FASD Hub Australia

The FASD Hub brings together the latest evidence-based content about alcohol, pregnancy and Fetal Alcohol Spectrum Disorder (FASD) in Australia.

Home

ATOMIC Ears: A Phase IIB randomised controlled trial to assess safety, tolerability and acceptability of a 5-day Dornase alfa treatment as an adjunct therapy to ventilation tube insertion for otitis media in children

Chris Jennifer Lea-Ann Peter Ruth Brennan-Jones Kent Kirkham Richmond Thornton PhD RN PhD MBBS MRCP(UK) FRACP PhD Head, Ear and Hearing Health

Defining the cellular immune response to vaccines for enhanced protection from invasive pneumococcal disease

Peter Lea-Ann Ruth Richmond Kirkham Thornton MBBS MRCP(UK) FRACP PhD PhD Head, Vaccine Trials Group Co-Head, Bacterial Respiratory Infectious Disease

Development of molecular tools for accurate diagnosis and disease surveillance (including vaccine impact)

Janessa Lea-Ann Peter Ruth Pickering Kirkham Richmond Thornton BSc PhD PhD MBBS MRCP(UK) FRACP PhD Senior Research Fellow (currently HOT NORTH Early